为了正常的体验网站,请在浏览器设置里面开启Javascript功能!

甲硝唑 [CAS443-48-1] 合成路线图解——原料药厂家武汉东康源

2019-07-09 6页 doc 63KB 136阅读

用户头像

is_841159

暂无简介

举报
甲硝唑 [CAS443-48-1] 合成路线图解——原料药厂家武汉东康源药物详细合成路线 Name Metronidazole;IDR-90105(Ophthalmic);Rosased;Zidoval;Metrogel;Flagyl Chemical Name 2-Methyl-5-nitro-1H-imidazole-1-ethanol CAS 443-48-1 Related CAS 133884-00-1 (deleted CAS) Formula C6H9N3O3 Structure Formula Weight 171.15693 Tel...
甲硝唑 [CAS443-48-1] 合成路线图解——原料药厂家武汉东康源
药物详细合成路线 Name Metronidazole;IDR-90105(Ophthalmic);Rosased;Zidoval;Metrogel;Flagyl Chemical Name 2-Methyl-5-nitro-1H-imidazole-1-ethanol CAS 443-48-1 Related CAS 133884-00-1 (deleted CAS) Formula C6H9N3O3 Structure Formula Weight 171.15693 Tel E-mail 027-******** 180******** 袁经理 chem@whdky.com Company 武汉东康源科技有限公司 Activity/Mechanism Acne Therapy, Antiamebics, Antibacterial Drugs, Antibacterial Ophthalmic Drugs, Antifungal Agents, ANTIINFECTIVE THERAPY, Antitrichomonals, DERMATOLOGIC DRUGS, Ocular Antiinflammatory and Antiinfective Agents, OCULAR MEDICATIONS, Ophthalmic Drugs, Treatment of Protozoal Diseases Syn. Route 6     Route 1 2-methylimidazole (i) is converted into the bisulfate salt, and then nitrated by means of a sulfonitric mixture in ac2o to produce 2-methyl-4-nitroimidazole (ii) . in a variant of this procedure, 2-methylimidazole (i) is nitrated by using a ferric nitrate-tonsyl adduct in several solvents. imidazole (ii) is then regioselectively alkylated with boiling 2-chloroethanol to produce the title compound. alternatively, the alkylation of (ii) has been reported by treatment with ethylene oxide (iii) under acidic conditions.   Route 2   in an alternative procedure, the title compound is obtained by hydrolysis of the bromoethyl imidazole (i) in the presence of formic acid in aqueous formamide   List of intermediates No.     Reference 1: sunjic, v.; fajdiga, t.; kajfez, f.; process for preparation of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole. de 1695321; gb 1138805; us 3520900 .     Route 3   the title compound can be obtained by reaction of 1-(acetoxymethyl)-2-methyl-4-nitroimidazole (i) with ethylene oxide (ii) in the presence of sulfur trioxide, followed by hydrolysis in aqueous h2so4   List of intermediates No. 3-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)-4-phenyl-1,4-dihydropyridine (ii)     Reference 1: lavigne, m.; mandard-cazin, b. (aventis pharma sa); process for preparing hydroxyalkyl-1 nitro-5 imidazoles. wo 9113877 .     Route 4   in a related procedure, 1-(acetoxymethyl)-2-methyl-4-nitroimidazole (i) is condensed with ethyleneglycol diacetate (ii) in the presence of anhydrous h2so4, followed by hydrolysis or alcoholysis under acidic conditions to produce the title compound   List of intermediates No.     Reference 1: buforn, a.; massonneau, v.; mulhauser, m. (aventis sa); process for the preparation of 1-hydroxyalkyl-2-methyl-5-nitro-imidazoles. ep 0325513; fr 2625999 .     Route 5   alternatively, 2-methyl-4-nitroimidazole (i) is protected by acylation in hot acetic anhydride to give (ii). addition of ethylene oxide (iii) to the n-acetyl imidazole (ii) in the presence of so3, followed by acidic hydrolysis furnishes the title compound   List of intermediates No. 3-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)-4-phenyl-1,4-dihydropyridine (iii) ethyl (1r,2s,4r)-2-isopropenyl-1-methyl-4-vinylcyclohexanecarboxylate (i)     Reference 1: lavigne, m.; mandard-cazin, b. (aventis pharma sa); process for preparing hydroxyalkyl-1 nitro-5 imidazoles. wo 9113877 .     Route 6   the title compound can also be obtained by alkylation, in different solvents, of 1-(acetoxymethyl)-2-methyl-4-nitroimidazole (i) with either ethylene sulfate (ii) or with bis-(2-acetoxyethyl) sulfate (iii) -generated from ethyleneglycol diacetate (iv) and either dimethyl sulfate or h2so4 - followed by hydrolysis or alcoholysis treatment   List of intermediates No.     Reference 1: massonneau, v.; mulhauser, m.; buforn, a. (aventis pharma sa); process for the preparation of hydroxyalkylating agents, the agents so prepared and their use. ep 0324692 . Reference 2: massonneau, v.; mulhauser, m.; buforn, a.; madard-cazin, b. (aventis pharma sa); process for the preparation of 1-hydroxyalkyl-5-nitro-imidazoles. ep 0324691 .      
/
本文档为【甲硝唑 [CAS443-48-1] 合成路线图解——原料药厂家武汉东康源】,请使用软件OFFICE或WPS软件打开。作品中的文字与图均可以修改和编辑, 图片更改请在作品中右键图片并更换,文字修改请直接点击文字进行修改,也可以新增和删除文档中的内容。
[版权声明] 本站所有资料为用户分享产生,若发现您的权利被侵害,请联系客服邮件isharekefu@iask.cn,我们尽快处理。 本作品所展示的图片、画像、字体、音乐的版权可能需版权方额外授权,请谨慎使用。 网站提供的党政主题相关内容(国旗、国徽、党徽..)目的在于配合国家政策宣传,仅限个人学习分享使用,禁止用于任何广告和商用目的。
热门搜索

历史搜索

    清空历史搜索